Citi lowered the firm’s price target on Bayer (BAYRY) to EUR 29 from EUR 30 and keeps a Neutral rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- Washington court to review Monsanto chemical victory case, WSJ reports
- AstraZeneca, CSPC deal shows Lp(a) space remains hot, says BMO Capital
- Trinity Biotech provides update on CGM technology collaboration with Bayer
- Freight Technologies secures win with Bayer
- A Promising Pipeline Ready to Break out at BridgeBio Pharma (BBIO)